Review of the Environmental Protection Agency’s Draft IRIS Assessment of Tetrachloroethylene

Committee to Review EPA’s Toxicological Assessment of Tetrachloroethylene

Board on Environmental Studies and Toxicology

Division on Earth and Life Studies

NATIONAL RESEARCH COUNCIL OF THE NATIONAL ACADEMIES

THE NATIONAL ACADEMIES PRESS

Washington, D.C.
www.nap.edu



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page R1
Review of the Environmental Protection Agency’s Draft IRIS Assessment of Tetrachloroethylene Committee to Review EPA’s Toxicological Assessment of Tetrachloroethylene Board on Environmental Studies and Toxicology Division on Earth and Life Studies

OCR for page R1
THE NATIONAL ACADEMIES PRESS 500 Fifth Street, NW Washington, DC 20001 NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Insti- tute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance. This project was supported by Contract 68-C-03-081 between the National Academy of Sciences and the U.S. Environmental Protection Agency. Any opinions, findings, conclu- sions, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the view of the organizations or agencies that provided support for this project. International Standard Book Number-13: 978-0-309-15094-1 International Standard Book Number-10: 0-309-15094-9 Additional copies of this report are available from The National Academies Press 500 Fifth Street, NW Box 285 Washington, DC 20055 800-624-6242 202-334-3313 (in the Washington metropolitan area) http://www.nap.edu Copyright 2010 by the National Academy of Sciences. All rights reserved. Printed in the United States of America.

OCR for page R1
The National Academy of Sciences is a private, nonprofit, self-perpetuating society of distinguished scholars engaged in scientific and engineering research, dedicated to the furtherance of science and technology and to their use for the general welfare. Upon the authority of the charter granted to it by the Congress in 1863, the Academy has a mandate that requires it to advise the federal government on scientific and technical matters. Dr. Ralph J. Cicerone is president of the National Academy of Sciences. The National Academy of Engineering was established in 1964, under the charter of the National Academy of Sciences, as a parallel organization of outstanding engineers. It is autonomous in its administration and in the selection of its members, sharing with the National Academy of Sciences the responsibility for advising the federal government. The National Academy of Engineering also sponsors engineering programs aimed at meeting national needs, encourages education and research, and recognizes the superior achievements of engineers. Dr. Charles M. Vest is president of the National Academy of Engineering. The Institute of Medicine was established in 1970 by the National Academy of Sciences to secure the services of eminent members of appropriate professions in the examination of policy matters pertaining to the health of the public. The Institute acts under the re- sponsibility given to the National Academy of Sciences by its congressional charter to be an adviser to the federal government and, upon its own initiative, to identify issues of medical care, research, and education. Dr. Harvey V. Fineberg is president of the Institute of Medicine. The National Research Council was organized by the National Academy of Sciences in 1916 to associate the broad community of science and technology with the Academy’s purposes of furthering knowledge and advising the federal government. Functioning in accordance with general policies determined by the Academy, the Council has become the principal operating agency of both the National Academy of Sciences and the Na- tional Academy of Engineering in providing services to the government, the public, and the scientific and engineering communities. The Council is administered jointly by both Academies and the Institute of Medicine. Dr. Ralph J. Cicerone and Dr. Charles M. Vest are chair and vice chair, respectively, of the National Research Council. www.national-academies.org

OCR for page R1

OCR for page R1
COMMITTEE TO REVIEW EPA’S TOXICOLOGICAL ASSESSMENT OF TETRACHLOROETHYLENE Members SAM KACEW (Chair), University of Ottawa, Ontario, Canada BRUCE H. ALEXANDER, University of Minnesota School of Public Health, Minneapolis MARGIT L. BLEECKER, Center for Occupational and Environmental Neurology, Baltimore, MD GARY P. CARLSON, Purdue University, West Lafayette, IN LINDA D. COWAN, University of Oklahoma Health Sciences Center, Oklahoma City MARY E. DAVIS, West Virginia University, Morgantown H. CHRISTOPHER FREY, North Carolina State University, Raleigh JOSEPH R. LANDOLPH, University of Southern California, Los Angeles M.E. (BETTE) MEEK, University of Ottawa, Ontario, Canada DAVID C. MCMILLAN, University of Nebraska Medical Center, Omaha M. CHRISTOPHER NEWLAND, Auburn University, Auburn, AL JULIA QUINT, California Department of Public Health (retired), Berkeley GARY L. ROSNER, University of Texas M.D. Anderson Cancer Center, Houston IVAN RUSYN, University of North Carolina, Chapel Hill ROLF SCHULTE-HERMANN, Medical University of Vienna, Austria IRVIN R. SCHULTZ, Battelle Pacific Northwest Division, Sequim, WA ROBERT SNYDER, Rutgers, the State University of New Jersey, Piscataway ROBERTA F. WHITE, Boston University School of Public Health, Boston, MA LUOPING ZHANG, University of California, Berkeley YILIANG ZHU, University of South Florida, Tampa Staff SUSAN N. J. MARTEL, Project Director NORMAN GROSSBLATT, Senior Editor MIRSADA KARALIC-LONCAREVIC, Manager, Technical Information Center KEEGAN SAWYER, Associate Program Officer TAMARA DAWSON, Program Associate RADIAH ROSE, Editorial Project Manager Sponsor U.S. ENVIRONMENTAL PROTECTION AGENCY v

OCR for page R1
BOARD ON ENVIRONMENTAL STUDIES AND TOXICOLOGY Members ROGENE F. HENDERSON (Chair), Lovelace Respiratory Research Institute, Albuquerque, NM RAMON ALVAREZ, Environmental Defense Fund, Austin, TX  TINA BAHADORI, American Chemistry Council, Arlington, VA MICHAEL J. BRADLEY, M.J. Bradley & Associates, Concord, MA DALLAS BURTRAW, Resources for the Future, Washington, DC JAMES S. BUS, Dow Chemical Company, Midland, MI JONATHAN Z. CANNON, University of Virginia, Charlottesville GAIL CHARNLEY, HealthRisk Strategies, Washington, DC RUTH DEFRIES, Columbia University, New York, NY RICHARD A. DENISON, Environmental Defense Fund, Washington, DC H. CHRISTOPHER FREY, North Carolina State University, Raleigh J. PAUL GILMAN, Covanta Energy Corporation, Fairfield, NJ RICHARD M. GOLD, Holland & Knight, LLP, Washington, DC LYNN R. GOLDMAN, Johns Hopkins University, Baltimore, MD JUDITH A. GRAHAM (retired), Pittsboro, NC HOWARD HU, University of Michigan, Ann Harbor ROGER E. KASPERSON, Clark University, Worcester, MA TERRY L. MEDLEY, E. I. du Pont de Nemours & Company, Wilmington, DE JANA MILFORD, University of Colorado at Boulder, Boulder DANNY D. REIBLE, University of Texas, Austin JOSEPH V. RODRICKS, ENVIRON International Corporation, Arlington, VA ROBERT F. SAWYER, University of California, Berkeley KIMBERLY M. THOMPSON, Harvard School of Public Health, Boston, MA MARK J. UTELL, University of Rochester Medical Center, Rochester, NY Senior Staff JAMES J. REISA, Director DAVID J. POLICANSKY, Scholar RAYMOND A. WASSEL, Senior Program Officer for Environmental Studies SUSAN N.J. MARTEL, Senior Program Officer for Toxicology ELLEN K. MANTUS, Senior Program Officer for Risk Analysis EILEEN N. ABT, Senior Program Officer RUTH E. CROSSGROVE, Senior Editor MIRSADA KARALIC-LONCAREVIC, Manager, Technical Information Center RADIAH ROSE, Manager, Editorial Projects vi

OCR for page R1
OTHER REPORTS OF THE BOARD ON ENVIRONMENTAL STUDIES AND TOXICOLOGY Contaminated Water Supplies at Camp Lejeune—Assessing Potential Health Effects (2009) Review of the Federal Strategy for Nanotechnology-Related Environmental, Health, and Safety Research (2009) Science and Decisions: Advancing Risk Assessment (2009) Phthalates and Cumulative Risk Assessment: The Tasks Ahead (2008) Estimating Mortality Risk Reduction and Economic Benefits from Controlling Ozone Air Pollution (2008) Respiratory Diseases Research at NIOSH (2008) Evaluating Research Efficiency in the U.S. Environmental Protection Agency (2008) Hydrology, Ecology, and Fishes of the Klamath River Basin (2008) Applications of Toxicogenomic Technologies to Predictive Toxicology and Risk Assessment (2007) Models in Environmental Regulatory Decision Making (2007) Toxicity Testing in the Twenty-first Century: A Vision and a Strategy (2007) Sediment Dredging at Superfund Megasites: Assessing the Effectiveness (2007) Environmental Impacts of Wind-Energy Projects (2007) Scientific Review of the Proposed Risk Assessment Bulletin from the Office of Management and Budget (2007) Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues (2006) New Source Review for Stationary Sources of Air Pollution (2006) Human Biomonitoring for Environmental Chemicals (2006) Health Risks from Dioxin and Related Compounds: Evaluation of the EPA Reassessment (2006) Fluoride in Drinking Water: A Scientific Review of EPA’s Standards (2006) State and Federal Standards for Mobile-Source Emissions (2006) Superfund and Mining Megasites—Lessons from the Coeur d’Alene River Basin (2005) Health Implications of Perchlorate Ingestion (2005) Air Quality Management in the United States (2004) Endangered and Threatened Species of the Platte River (2004) Atlantic Salmon in Maine (2004) Endangered and Threatened Fishes in the Klamath River Basin (2004) Cumulative Environmental Effects of Alaska North Slope Oil and Gas Development (2003) Estimating the Public Health Benefits of Proposed Air Pollution Regulations (2002) Biosolids Applied to Land: Advancing Standards and Practices (2002) The Airliner Cabin Environment and Health of Passengers and Crew (2002) vii

OCR for page R1
Arsenic in Drinking Water: 2001 Update (2001) Evaluating Vehicle Emissions Inspection and Maintenance Programs (2001) Compensating for Wetland Losses Under the Clean Water Act (2001) A Risk-Management Strategy for PCB-Contaminated Sediments (2001) Acute Exposure Guideline Levels for Selected Airborne Chemicals (seven volumes, 2000-2009) Toxicological Effects of Methylmercury (2000) Strengthening Science at the U.S. Environmental Protection Agency (2000) Scientific Frontiers in Developmental Toxicology and Risk Assessment (2000) Ecological Indicators for the Nation (2000) Waste Incineration and Public Health (2000) Hormonally Active Agents in the Environment (1999) Research Priorities for Airborne Particulate Matter (four volumes, 1998-2004) The National Research Council’s Committee on Toxicology: The First 50 Years (1997) Carcinogens and Anticarcinogens in the Human Diet (1996) Upstream: Salmon and Society in the Pacific Northwest (1996) Science and the Endangered Species Act (1995) Wetlands: Characteristics and Boundaries (1995) Biologic Markers (five volumes, 1989-1995) Science and Judgment in Risk Assessment (1994) Pesticides in the Diets of Infants and Children (1993) Dolphins and the Tuna Industry (1992) Science and the National Parks (1992) Human Exposure Assessment for Airborne Pollutants (1991) Rethinking the Ozone Problem in Urban and Regional Air Pollution (1991) Decline of the Sea Turtles (1990) Copies of these reports may be ordered from the National Academies Press (800) 624-6242 or (202) 334-3313 www.nap.edu viii

OCR for page R1
Preface In June 2008, the U.S. Environmental Protection Agency (EPA) released its draft Toxicological Review of Tetrachloroethylene (Perchloroethylene) (CAS No. 127-18-4) in Support of Summary Information on the Integrated Risk Information System (IRIS). The assessment provided estimates of cancer and noncancer effects, which will be used to establish air and water quality standards to protect public health and set cleanup standards for hazardous-waste sites. EPA requested that the National Research Council review the scientific evidence on the adverse health ef- fect of tetrachloroethylene and the agency’s application of such data in quantifying human health risks. The review was sought to ensure that the draft IRIS assessment was consistent with current EPA guidance on conducting risk assessments and that it reflected sound scientific analysis and judgment. In response to EPA’s request, the National Research Council convened the Committee to Review EPA’s Toxicological Assessment of Tetrachloroethylene, which prepared this report. The members of the committee were selected for their expertise in pharmacokinetics, liver toxicology, kidney toxicology, neurotoxicology, hematopoietic toxicology, reproductive toxicology, developmental toxicology, geno- toxicity, carcinogenesis, epidemiology, physiologically based pharmacokinetic mod- eling, biostatistics, and risk assessment. Biographic information on the committee members is provided in Appendix A. To help the committee in its review, public meetings were held in November 2008 and January and April 2009 to gather information from EPA, academic and industry researchers, state public-health departments, and the general public. The committee is grateful to those who gave presentations on research related to tetrachloroethylene or on topics relevant to the committee’s task, including Judith Schreiber, Office of the New York State Attorney General; Philip Bushnell, EPA; Thomas Burke, Johns Hopkins Bloomberg School of Public Health; Andy Salmon, California Environmental Protection Agency; and Harvey Clewell III, Hamner Institutes for Health Sciences. The committee also thanks Peter Preuss, Kathryn Guyton, and Karen Hogan for providing background information and responding to questions throughout the study. One committee member, Rolf Schulte-Hermann, disagreed with the commit- tee’s support of EPA’s conclusion that the mode of action of tetrachloroethylene in inducing liver cancer in rodents is unknown. He judges that the induction of liver cancer in mice can be fully explained by a mode of action that involves the activa- tion of the peroxisome proliferator-activated receptor-alpha. The basis of his judg- ix

OCR for page R1
x Preface ment and of his dissent from the committee’s position is detailed in Appendix B, where it is followed by the committee’s rebuttal. This report and the dissenting statement have been reviewed in draft form by persons chosen for their diverse perspectives and technical expertise in accordance with procedures approved by the National Research Council’s Report Review Com- mittee. The purpose of the independent review is to provide candid and critical comments that will assist the institution in making its published report as sound as possible and to ensure that the report meets institutional standards of objectivity, evidence, and responsiveness to the study charge. The review comments and draft manuscript remain confidential to protect the integrity of the deliberative process. We thank the following for their review of this report: A. John Bailer, Miami Uni- versity; Lucio Costa, University of Washington; Scott E. Bowen, Wayne State Uni- versity; Wolfgang Dekant, University of Würzburg; Adnan Elfarra, University of Wisconsin; Jeffrey Fisher, University of Georgia; David H. Garabrant, University of Michigan; Bernard D. Goldstein, University of Pittsburgh; David G. Hoel, Medical University of South Carolina; Ronald Melnick, National Institute of Environmental Health Sciences; Dorothy Patton, Environmental Protection Agency (retired); David Richardson, University of North Carolina School of Public Health; and Lauren Zeise, California Environmental Protection Agency. Although the reviewers listed above provided many constructive comments and suggestions, they were not asked to endorse the conclusions or recommenda- tions, nor did they see the final draft of the report before its release. The review of the report was overseen by the review coordinator, David Eaton, University of Washington, and review monitor, Mark Cullen, Yale University. Appointed by the National Research Council, they were responsible for making certain that an inde- pendent examination of the report was carried out in accordance with institutional procedures and that all review comments were carefully considered. Responsibility for the final content of the report rests entirely with the author committee and the institution. The committee is grateful for the assistance of National Research Council staff in preparing the report, in particular Susan Martel, who served as project director and contributed to the report. Other staff members who contributed are James Reisa, director of the Board on Environmental Studies and Toxicology; Keegan Sawyer, associate program officer; Norman Grossblatt, senior editor; Mirsada Karalic- Loncarevic, manager of the Technical Information Center; Radiah Rose, editorial projects manager; and Tamara Dawson, program associate. Finally, I thank all the members of the committee for their time and efforts throughout the development of this report. Sam Kacew, Chair Committee to Review EPA’s Toxicological Assessment of Tetrachloroethylene

OCR for page R1
Abbreviations AUC area under the curve BMC benchmark concentration BMCL benchmark concentration with its lower confidence limit BMD benchmark dose BuChE butyrylcholinesterase CCI color-confusion index CFU colony-forming unit CHO Chinese hamster ovary CI confidence interval CNS central nervous system CYP cytochrome P-450 DCA dichloroacetic acid DEHP diethylhexylphthalate EBV Epstein Barr virus 8-OHdG 8-hydroxydeoxyguanosine EPA U.S. Environmental Protection Agency FDA Food and Drug Administration FMO flavin-containing monooxygenase GJIC gap junctional intercellular communication GSH glutathione GST glutathione S-transferase HD Hodgkin disease IARC International Agency for Research on Cancer IRIS Integrated Risk Information System JEM job-exposure matrix JISA Japan Industrial Safety Association JTEM job-task exposure matrix LGLL large granular lymphocytic leukemia LOAEL lowest observed-adverse-effect level MCL mononuclear-cell leukemia MOA mode of action N-acetyl-S-(1,2,2-trichlorovinyl)-L-cysteine N-Ac-TCVCS xi

OCR for page R1
xii Abbreviations NCI National Cancer Institute NES Neurobehavioral Evaluation System NHL non-Hodgkin lymphoma NK natural-killer NOAEL no-observed-adverse-effect level NRC National Research Council NTP National Toxicology Program OECD Organisation for Economic Co-operation and Development OR odds ratio PBPK physiologically based pharmacokinetic modeling PCO palmitoyl-CoA oxidation POD point of departure PPARα peroxisome proliferator-activated receptor-alpha RCC renal-cell carcinoma RfC reference concentration RfD reference dose RfV reference value SAB Science Advisory Board SCE sister-chromatid exchange SIR standardized incidence ratio SMR standardized mortality ratio TCA trichloroacetic acid S-(1,2,2-trichlorovinyl)-L-cysteine TCVC TCVCS S-(1,2,2-trichlorovinyl)-L-cysteine sulfoxide TCVG S-(1,2,2-trichlorovinyl) glutathione TWA time-weighted average VCS visual-contrast sensitivity VEP visual evoked potential WHO World Health Organization

OCR for page R1
Contents ABBREVIATIONS ......................................................................................................... xi SUMMARY ...................................................................................................................... 3 1 INTRODUCTION .................................................................................................. 16 Statement of Task, 17 Committee’s Approach, 21 Consideration of Mode of Action, 22 Organization of Committee’s Report, 23 2 OVERVIEW OF THE TOXICOKINETICS OF TETRACHLOROETHYLENE ............................................................................ 24 The Cytochrome P-450 Pathway, 26 The β-lyase Pathway, 27 The β-lyase Independent Pathway, 28 Species Differences, 28 3 NEUROTOXICITY .............................................................................................. 30 Human Studies, 30 Animal Studies, 37 Developmental Neurotoxicity, 39 Findings and Recommendations, 41 4 REPRODUCTIVE AND DEVELOPMENTAL EFFECTS ................................ 42 Limitations of the Database, 43 Combined Discussion of Reproductive and Developmental Toxicity, 43 Evaluation of the Relationship of Maternal and Developmental Toxicity, 44 Study Strengths and Limitations and Consistency of Results, 44 Strength of Evidence, 45 Attributing Developmental Toxicity to Trichloroacetic Acid, 46 Epidemiologic Studies, 46 Findings and Recommendations, 48 5 GENOTOXICITY .................................................................................................. 50 Organization and Evaluation of Data, 50 Studies of Tetrachloroethylene, 51 Studies of Metabolites of Tetrachloroethylene, 54 xiii

OCR for page R1
xiv Contents Evidence for Indirect Genotoxicity, 55 Formation of Reactive Metabolites in Animals and Humans, 56 Cell-Transformation Assays, 56 Findings and Recommendations, 57 6 HEPATIC TOXICITY AND CANCER ............................................................... 59 Hepatotoxicity, 59 Hepatocarcinogencity, 61 Summary, 66 7 RENAL TOXICITY AND CANCER ................................................................... 68 Human Studies, 68 Animal Studies, 70 Summary and Recommendations, 73 8 HEMATOPOIETIC EFFECTS ............................................................................ 75 Animal Studies, 75 Human Studies, 78 Mode of Action, 78 Summary, 80 9 GENERAL REVIEW OF EPIDEMIOLOGIC EVIDENCE PERTAINING TO CANCER ................................................................................ 81 Esophageal Cancer, 83 Lymphoid Cancers, 84 Other Cancers, 84 General Comments on the Environmental Protection Agency’s Presentation on Epidemiologic Evidence on Cancer, 85 Research Recommendations, 85 10 REFERENCE VALUES FOR TETRACHLOROETHYLENE ......................... 86 Selection of Critical End Point and Studies, 86 Dose Metrics, 89 Route-to-Route Extrapolation, 89 Characterization of Uncertainties, 90 Graphical Presentation of Reference Values, 93 11 CANCER RISK ESTIMATES FOR TETRACHLOROETHYLENE............... 98 Cancer Classification, 98 Selection of Tumor Type for Quantitative Assessment, 101 Mode of Action Analysis, 102 Age-Dependent Adjustment Factor, 103 Low-Dose Extrapolation, 104 Physiologically Based Pharmacokinetic Models, Dose Metrics, and Interspecies Scaling, 106 Uncertainty, 112 12 MOVING BEYOND THE CURRENT STATE OF PRACTICE ..................... 114 Organization and Approach, 114 Uncertainty Assessment, 116

OCR for page R1
xv Contents REFERENCES ............................................................................................................. 121 APPENDIXES A BIOGRAPHIC INFORMATION ON THE COMMITTEE ON TETRACHLOROETHYLENE .......................................................................... 137 B DISSENTING STATEMENT AND REBUTTAL ............................................. 144 BOXES, FIGURES, AND TABLES BOXES 11-1 EPA Cancer Guidance for Concluding a Chemical is Likely to be Carcinogenic to Humans (EPA 2005), 99 FIGURES S-1 Distribution of sample reference values, 7 2-1 Simplified illustration of the metabolic pathways of tetrachloroethylene, 26 10-1 Distribution of sample reference values, 94 TABLES 3-1 Estimated Meana Neuropsychologic Test Results by Lifetime Exposure to Tetrachloroethylene in Study by Echeverria et al. (1995), 35 11-1 Summary of Data on Hepatic Metabolism of Tetrachloroethylene and Urinary Excretion of Glutathione-Pathway Metabolites, 110

OCR for page R1